Table 4.

Colonic mucosal protein expression of PPARγ, NF-κB, and TNF-α (mean ± SD).

Time	Control group			Model group			Rosiglitazone-treated group
	PPARγ	NF-κB	TNF-α	PPARγ	NF-κB	TNF-α	PPARγ	NF-κB	TNF-α
7th d	0.04 ± 0.01	0.02 ± 0.01	0.01 ± 0.00	0.01 ± 0.00*	0.13 ± 0.01*	0.10 ± 0.01*	0.02 ± 0.01Δ	0.09 ± 0.01Δ	0.08 ± 0.01Δ
14th d	0.04 ± 0.00	0.02 ± 0.00	0.001 ± 0.00	0.00 ± 0.00*	0.11 ± 0.01*	0.07 ± 0.01*	0.02 ± 0.00Δ	0.07 ± 0.01Δ	0.05 ± 0.01Δ
21st d	0.04 ± 0.01	0.03 ± 0.00	0.00 ± 0.00	0.01 ± 0.00*	0.09 ± 0.01*	0.06 ± 0.01*	0.02 ± 0.01Δ	0.06 ± 0.01Δ	0.02 ± 0.01Δ
35th d	0.04 ± 0.00	0.02 ± 0.01	0.01 ± 0.00	0.01 ± 0.00*	0.07 ± 0.01*	0.05 ± 0.01*	0.03 ± 0.01Δ	0.04 ± 0.00Δ	0.02 ± 0.00Δ

Note: *P < 0.05 versus control group, ^Δ P < 0.05 versus model group.